- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hypometabolism in Healthy Brains May Indicate Pre-Alzheimer’s
PET finds hypometabolism in healthy brains that may indicate pre-Alzheimer’s disease.
PET images detected an association between hypometabolism and amyloid in brains of people with pre-Alzheimer’s who don’t show any signs of cognitive decline, according to presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 annual meeting.
The amyloid plaque build-up in the brain in Alzheimer’s is known, but now there appears to be a connection between the amyloid burden and hypometabolism of neurons in parts of the brain that have been associated with Alzheimer’s disease.
“Previous studies indicate that hypometabolism of this same pattern is present in people who have abnormalities of the gene apolipoprotein E, or APOE,” Val J. Lowe, MD, professor of radiology at Mayo Clinic Cancer Center, said in a release. “Hypometabolism does appear to be an early harbinger of the disease before dementia sets in.”.
Researchers from the Mayo Clinic Study of Aging studied PET images of 617 cognitively normal subjects. Each subject first underwent imaging with the amyloid-binding radionuclide imaging agent C-11 Pittsburgh compound B (PiB), followed an hour later with a second exam which used F018 fluorodeoxyglucose (FDG).
The researchers found that there was significant hypometabolism in brain regions classically associated with Alzheimer’s disease, including the angular gyrus and posterior cingulate.
The researchers will continue to follow the subjects to see if they progress to Alzheimer’s disease, and to study the ones do not develop the disease but do have amyloid in their brain.
Emerging PSMA PET Agent May Offer Improved Detection of Prostate Cancer
September 7th 2023The PSMA PET agent 64Cu SAR-bisPSMA detected a higher number of prostate cancer lesions and had a significantly higher SUVmax and SUVmean than 68Ga PSMA-11 PET/CT, according to initial data from a prospective multisite study presented at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
Emerging PET Radiotracer May Offer Multiple Advantages in Detecting Prostate Cancer
August 3rd 2023The PET radiotracer 18F-PSMA-1007 facilitated detection of at least one suspicious lesion for metastasis in nearly half of a cohort of 160 patients with prostate cancer, according to research presented recently at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
Hybrid PET/MRI Assessment with Hippocampal Radiomics May Facilitate Early Alzheimer's Diagnosis
June 30th 2023Employing a hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) model to assess predictive features of Alzheimer’s disease (AD), researchers noted a 100 percent sensitivity rate and a 93 percent sensitivity rate for distinguishing between AD and normal cognition, according to a study presented at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago.
